Stock Scorer

‹ ETFs

Virtus LifeSci Biotech Products ETF (BBP)

Every component of BBP and its weight in the fund, as of 2026-10-19.

ComponentWeight%Sector
MRNAModerna Inc · United States 5.77% Healthcare
IOVAIovance Biotherapeutics Inc · United States 4.44% Healthcare
VSTMVerastem Inc · United States 2.74% Healthcare
OMEROmeros Corporation · United States 2.46% Healthcare
HALOHalozyme Therapeutics Inc · United States 2.34% Healthcare
XERSXeris Pharmaceuticals Inc · United States 2.03% Healthcare
KNSAKiniksa Pharmaceuticals Ltd · United States 1.98% Healthcare
BGNEBeiGene Ltd · United States 1.90% Healthcare
RIGLRigel Pharmaceuticals Inc · United States 1.84% Healthcare
ZLABZai Lab Ltd · United States 1.83% Healthcare
PGENPrecigen Inc · United States 1.83% Healthcare
NKNantKwest Inc · United States 1.75% Healthcare
NVAXNovavax Inc · United States 1.70% Healthcare
ADMAADMA Biologics Inc · United States 1.69% Healthcare
AMGNAmgen Inc · United States 1.68% Healthcare
GILDGilead Sciences Inc · United States 1.67% Healthcare
REGNRegeneron Pharmaceuticals Inc · United States 1.65% Healthcare
PTGXProtagonist Therapeutics Inc · United States 1.65% Healthcare
BIIBBiogen Inc · United States 1.63% Healthcare
EXELExelixis Inc · United States 1.59% Healthcare
ARQTArcutis Biotherapeutics Inc · United States 1.57% Healthcare
SRPTSarepta Therapeutics Inc · United States 1.53% Healthcare
ROIVRoivant Sciences Ltd · United States 1.50% Healthcare
LGNDLigand Pharmaceuticals Incorporated · United States 1.50% Healthcare
VRTXVertex Pharmaceuticals Inc · United States 1.49% Healthcare
ZA8ZYMEWORKS DL-00001 · Germany 1.46% Healthcare
TGTXTG Therapeutics Inc · United States 1.46% Healthcare
AUPAurinia Pharmaceuticals Inc · Canada 1.46% Technology
AGIOAgios Pharm · United States 1.45% Healthcare
HRMYHarmony Biosciences Holdings · United States 1.44% Healthcare
TARSTarsus Pharmaceuticals Inc · United States 1.44% Healthcare
IMCRImmunocore Holdings Ltd · United States 1.41% Healthcare
INCYIncyte Corporation · United States 1.38% Healthcare
ASNDAscendis Pharma AS · United States 1.37% Healthcare
CRSPCrispr Therapeutics AG · United States 1.37% Healthcare
KURAKura Oncology Inc · United States 1.36% Healthcare
BBIOBridgeBio Pharma Inc · United States 1.35% Healthcare
GERNGeron Corporation · United States 1.35% Healthcare
RYTMRhythm Pharmaceuticals Inc · United States 1.33% Healthcare
INSMInsmed Inc · United States 1.32% Healthcare
KRYSKrystal Biotech Inc · United States 1.32% Healthcare
TVTXTravere Therapeutics Inc · United States 1.30% Healthcare
BNTXBioNTech SE · United States 1.29% Healthcare
BMRNBiomarin Pharmaceutical Inc · United States 1.27% Healthcare
UTHRUnited Therapeutics Corporation · United States 1.27% Healthcare
ACADACADIA Pharmaceuticals Inc · United States 1.26% Healthcare
BCRXBioCryst Pharmaceuticals Inc · United States 1.25% Healthcare
IRWDIronwood Pharmaceuticals Inc · United States 1.24% Healthcare
MDGLMadrigal Pharmaceuticals Inc · United States 1.24% Healthcare
CYTKCytokinetics Inc · United States 1.18% Healthcare
NUVBNuvation Bio Inc · United States 1.17% Healthcare
ALNYAlnylam Pharmaceuticals Inc · United States 1.10% Healthcare
NBIXNeurocrine Biosciences Inc · United States 1.09% Healthcare
MIRMMirum Pharmaceuticals Inc · United States 1.08% Healthcare
PTCTPTC Therapeutics Inc · United States 1.08% Healthcare
DNLIDenali Therapeutics Inc · United States 1.07% Healthcare
ARWRArrowhead Pharmaceuticals Inc · United States 1.02% Healthcare
SNDXSyndax Pharmaceuticals Inc · United States 0.99% Healthcare
PHATPhathom Pharmaceuticals Inc · United States 0.94% Healthcare
RAREUltragenyx · United States 0.83% Healthcare
AXSMAxsome Therapeutics Inc · United States 0.80% Healthcare
IONSIonis Pharmaceuticals Inc · United States 0.79% Healthcare
ARDXArdelyx Inc · United States 0.71% Healthcare
LEGNLegend Biotech Corp · United States 0.67% Healthcare
LQDALiquidia Technologies Inc · United States 0.64% Healthcare

From the market data provider's fund data, read 2026-10-19. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.